Please provide your email address to receive an email when new articles are posted on . Nevro Corp. has announced FDA approval for expanded labeling of its Senza spinal cord stimulation system for use ...

The new labeling will include outcomes from a study showing “superior back pain relief” compared to conventional spinal cord stimulation, according to a March 17 news release. Eighty-four percent of ...

Please provide your email address to receive an email when new articles are posted on . Expanded labeling allows those with chronic pain to have a wider selection of leads for full-body scans. Eterna ...

(RTTNews) - Nevro Corp. (NVRO) announced receipt of FDA approval for expanded labeling for its Senza Spinal Cord Stimulation System for the treatment of Non-Surgical Refractory Back Pain. The approval ...

The US Food and Drug Administration (FDA) has approved expanded MRI labeling for Abbott Laboratories' Eterna spinal cord stimulation (SCS) system, which will allow for higher-quality scan images for ...

Recommendations from research published today on the diagnosis and treatment of spinal cord damage caused by nitrous oxide abuse have been simultaneously adopted as official clinical practice ...

Twelve physician groups expressed their “profound objection” to Humana’s classification of a spinal procedure as “unproven” in a letter to the healthcare insurer. The letter, sent Oct. 9 to Manisha ...